Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Meredith Verret's research focuses on the interpretation of biomarkers in the classification of squamous cell carcinoma, particularly in the vulva. A 2024 publication investigated the interobserver agreement in the interpretation of p16 and p53 in this context. Verret has also examined the spectrum of malignant diagnoses within cerebrospinal fluid cytology in adult populations, contributing to multi-institutional retrospective reviews published in 2023 and 2024. Verret's work involves collaborations with Susanne K. Jeffus, Sarah Vestal, Charles M. Quick, and Jacob T. Wooldridge, all affiliated with the University of Arkansas for Medical Sciences. With a h-index of 2 and 12 total citations across 4 publications, Verret is an active researcher in the field.
Metrics
- h-index: 2
- Publications: 4
- Citations: 14
Selected Publications
-
Interpretation of p16 and p53 in the Classification of Squamous Cell Carcinoma of the Vulva—An Interobserver Agreement Study (2024)
-
In reply: Malignant tumor diagnoses in cerebrospinal fluid cytology (2024)
-
The spectrum of malignant diagnoses in cerebrospinal fluid cytology from an adult population: a multi-institutional retrospective review (2023)
-
The Spectrum of Malignant Diagnoses in Cerebrospinal Fluid Cytology from an Adult Population – A Multi-Institutional Retrospective Review (2023)
Collaboration Network
Top Collaborators
- The spectrum of malignant diagnoses in cerebrospinal fluid cytology from an adult population: a multi-institutional retrospective review
- Interpretation of p16 and p53 in the Classification of Squamous Cell Carcinoma of the Vulva—An Interobserver Agreement Study
- The Spectrum of Malignant Diagnoses in Cerebrospinal Fluid Cytology from an Adult Population – A Multi-Institutional Retrospective Review
- In reply: Malignant tumor diagnoses in cerebrospinal fluid cytology
- The spectrum of malignant diagnoses in cerebrospinal fluid cytology from an adult population: a multi-institutional retrospective review
- The Spectrum of Malignant Diagnoses in Cerebrospinal Fluid Cytology from an Adult Population – A Multi-Institutional Retrospective Review
- In reply: Malignant tumor diagnoses in cerebrospinal fluid cytology
- The spectrum of malignant diagnoses in cerebrospinal fluid cytology from an adult population: a multi-institutional retrospective review
- The Spectrum of Malignant Diagnoses in Cerebrospinal Fluid Cytology from an Adult Population – A Multi-Institutional Retrospective Review
- In reply: Malignant tumor diagnoses in cerebrospinal fluid cytology
- The spectrum of malignant diagnoses in cerebrospinal fluid cytology from an adult population: a multi-institutional retrospective review
- The Spectrum of Malignant Diagnoses in Cerebrospinal Fluid Cytology from an Adult Population – A Multi-Institutional Retrospective Review
- In reply: Malignant tumor diagnoses in cerebrospinal fluid cytology
- The spectrum of malignant diagnoses in cerebrospinal fluid cytology from an adult population: a multi-institutional retrospective review
- The Spectrum of Malignant Diagnoses in Cerebrospinal Fluid Cytology from an Adult Population – A Multi-Institutional Retrospective Review
- In reply: Malignant tumor diagnoses in cerebrospinal fluid cytology
- The spectrum of malignant diagnoses in cerebrospinal fluid cytology from an adult population: a multi-institutional retrospective review
- The Spectrum of Malignant Diagnoses in Cerebrospinal Fluid Cytology from an Adult Population – A Multi-Institutional Retrospective Review
- In reply: Malignant tumor diagnoses in cerebrospinal fluid cytology
- The spectrum of malignant diagnoses in cerebrospinal fluid cytology from an adult population: a multi-institutional retrospective review
- In reply: Malignant tumor diagnoses in cerebrospinal fluid cytology
- Interpretation of p16 and p53 in the Classification of Squamous Cell Carcinoma of the Vulva—An Interobserver Agreement Study
- Interpretation of p16 and p53 in the Classification of Squamous Cell Carcinoma of the Vulva—An Interobserver Agreement Study
- Interpretation of p16 and p53 in the Classification of Squamous Cell Carcinoma of the Vulva—An Interobserver Agreement Study
- Interpretation of p16 and p53 in the Classification of Squamous Cell Carcinoma of the Vulva—An Interobserver Agreement Study
- Interpretation of p16 and p53 in the Classification of Squamous Cell Carcinoma of the Vulva—An Interobserver Agreement Study
- Interpretation of p16 and p53 in the Classification of Squamous Cell Carcinoma of the Vulva—An Interobserver Agreement Study
- Interpretation of p16 and p53 in the Classification of Squamous Cell Carcinoma of the Vulva—An Interobserver Agreement Study
- Interpretation of p16 and p53 in the Classification of Squamous Cell Carcinoma of the Vulva—An Interobserver Agreement Study
Similar Researchers
Based on overlapping research topics